Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Orgenesis Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q2 2023
- Shares held
- 2.22M
- −602.2K (−21.3%) vs. Q2 2023
- Total value
- $1.37M
- −$2.55M (−65.0%) vs. Q2 2023
- New holders
- 3
- 3 more added
- Sold out
- 4
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $20.8K |
| Q1 2026 | 1 | $30.4K |
| Q4 2025 | 1 | $7.59K |
| Q3 2025 | 1 | $50.6K |
| Q2 2025 | 1 | $74.7K |
| Q1 2025 | 1 | $124.0K |
| Q4 2024 | 1 | $95.7K |
| Q3 2024 | 12 | $958.5K |
| Q2 2024 | 20 | $1.31M |
| Q1 2024 | 18 | $1.82M |
| Q4 2023 | 21 | $1.10M |
| Q3 2023 | 22 | $1.37M |
| Q2 2023 | 23 | $3.93M |
| Q1 2023 | 21 | $3.15M |
| Q4 2022 | 21 | $4.33M |
| Q3 2022 | 23 | $4.15M |
| Q2 2022 | 22 | $7.07M |
| Q1 2022 | 23 | $10.2M |
| Q4 2021 | 27 | $8.78M |
| Q3 2021 | 28 | $15.5M |
| Q2 2021 | 34 | $17.8M |
| Q1 2021 | 40 | $30.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Orgenesis Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 117 | $0 | 0.00% | −166−58.7% | Reduced |
| Qube Research & Technologies Ltd | 1 | $1 | 0.00% | +1 | New |
| UBS Group AG | 67 | $42 | 0.00% | −432−86.6% | Reduced |
| BNP Paribas Arbitrage, SA | 75 | $46 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 129 | $79 | 0.00% | +34+35.8% | Added |
| Wells Fargo & Company | 193 | $120 | 0.00% | +3+1.6% | Added |
| Bank of America Corp | 200 | $124 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,330 | $3.92K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6,880 | $4.27K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 18,330 | $11.0K | 0.00% | +18,330 | New |
| Prudential Financial Inc | 19,000 | $11.5K | 0.00% | +19,000 | New |
| Chapin Davis, Inc. | 20,000 | $12.4K | 0.01% | 00.0% | Unchanged |
| Walleye Capital LLC | 28,028 | $17.0K | 0.00% | −43,212−60.7% | Reduced |
| Bank Hapoalim BM | 32,052 | $20.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 41,227 | $25.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 43,604 | $27.0K | 0.00% | −2,295−5.0% | Reduced |
| State Street Corp | 88,659 | $53.9K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 117,784 | $73.0K | 0.00% | −14,788−11.2% | Reduced |
| Geode Capital Management, LLC | 239,264 | $145.4K | 0.00% | +32,510+15.7% | Added |
| Knoll Capital Management, LLC | 634,738 | $393.5K | 0.41% | 00.0% | Unchanged |
| Vanguard Group Inc | 924,806 | $573.4K | 0.00% | 00.0% | Unchanged |
| Redmond Asset Management, LLC | 0 | $0 | 0.00% | −579,980−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −16,541−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −12,529−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,156−100.0% | Sold out |